The Research & Development team at Quotient Therapeutics is dedicated to advancing the Somatic Genomics platform by exploring genetic variations to inform the creation of innovative therapeutic solutions. Comprising experts in engineering, bioinformatics, and genomic sciences, the team collaborates to design experiments, analyze data, and translate findings into novel medicines that address unmet medical needs. Their work combines cutting-edge technology with strategic insight to drive the development of transformational healthcare solutions.
Andrew Joad
Senior Engineer II
Gerda Kildisiute
Scientist II
Hannah Cabot
Senior Manager, R&d Strategy
Inigo Martincorena
Group Leader, Sanger Institute
Mike Stratton
Senior Group Leader, Sanger In...
Peter Campbell
Senior Group Leader, Sanger In...
Rachael Godfrey
Senior Research Associate
Raúl Alcántara Aragó...
Senior Bioinformatics Engineer
Timothy Butler
Principal Scientist
Tobias Tilly
AI Scientist